Gherman, A.; Balacescu, L.; Popa, C.; Cainap, C.; Vlad, C.; Cainap, S.S.; Balacescu, O.
Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer. Int. J. Mol. Sci. 2023, 24, 10622.
https://doi.org/10.3390/ijms241310622
AMA Style
Gherman A, Balacescu L, Popa C, Cainap C, Vlad C, Cainap SS, Balacescu O.
Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer. International Journal of Molecular Sciences. 2023; 24(13):10622.
https://doi.org/10.3390/ijms241310622
Chicago/Turabian Style
Gherman, Alexandra, Loredana Balacescu, Calin Popa, Calin Cainap, Catalin Vlad, Simona S. Cainap, and Ovidiu Balacescu.
2023. "Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer" International Journal of Molecular Sciences 24, no. 13: 10622.
https://doi.org/10.3390/ijms241310622
APA Style
Gherman, A., Balacescu, L., Popa, C., Cainap, C., Vlad, C., Cainap, S. S., & Balacescu, O.
(2023). Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer. International Journal of Molecular Sciences, 24(13), 10622.
https://doi.org/10.3390/ijms241310622
